Arthur Greenberg Insider Profile
4 Followers
Arthur Greenberg, Director at Galectin Therapeutics, holds 109.44K shares in Galectin Therapeutics (Ticker: GALT). Most recently, Arthur Greenberg Bought 1,666 shares of Galectin Therapeutics on Jan 07, 2016 for an estimated value of $2.87K.
Arthur Greenberg's Trading History
| GALTGalectin Therapeutics | Jan 07, 2016 | Director | Informative Buy | 2.87K | $343.66K | |
GALT Insider Shares: 109.44K (0.46%) | ||||||
You May Also Like
Arthur Greenberg insider profile FAQ
What is the percentage of profitable transactions made by Arthur Greenberg?
The percentage of profitable transactions made by Arthur Greenberg is 0%.
What is the average return per transaction made by Arthur Greenberg?
The average return per transaction made by Arthur Greenberg is -47.10%.
What stocks does Arthur Greenberg hold?
Arthur Greenberg holds: GALT stocks.
What was Arthur Greenberg’s latest transaction?
Arthur Greenberg’s latest transaction was an Informative Buy of $2.87K.
What was Arthur Greenberg's most profitable transaction?
Arthur Greenberg’s most profitable transaction was an Informative Buy of GALT stock on January 7, 2016. The return on the trade was -33.10%.
What is Arthur Greenberg's role in Galectin Therapeutics?
Arthur Greenberg's role in Galectin Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
